Orchestrated activation of mGluR5 and CB1 promotes neuroprotection

The metabotropic glutamate receptor 5 (mGluR5) and the cannabinoid receptor 1 (CB1) exhibit a functional interaction, as CB1 regulates pre-synaptic glutamate release and mGluR5 activation increases endocannabinoid synthesis at the post-synaptic site. Since both mGluR5 and CB1 promote neuroprotection, we delineated experiments to investigate a possible link between CB1 and mGluR5 activation in the induction of neuroprotection using primary cultured corticostriatal neurons. We find that either the pharmacological blockade or the genetic ablation of either mGluR5 or CB1 can abrogate both CB1- and mGluR5-mediated neuroprotection against glutamate insult. Interestingly, decreased glutamate release and diminished intracellular Ca2+ do not appear to play a role in CB1 and mGluR5-mediated neuroprotection. Rather, these two receptors work cooperatively to trigger the activation of cell signaling pathways to promote neuronal survival, which involves MEK/ERK1/2 and PI3K/AKT activation. Interestingly, although mGluR5 activation protects postsynaptic terminals and CB1 the presynaptic site, intact signaling of both receptors is required to effectively promote neuronal survival. In conclusion, mGluR5 and CB1 act in concert to activate neuroprotective cell signaling pathways and promote neuronal survival.

• Publication year

  2016

• Venue

  Molecular Brain

• Publication date

  2016-08-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1186/s13041-016-0259-6PMID 27543109PMCID 4992217
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alzheimer’s Disease: Lessons Learned from Amyloidocentric Clinical Trials

  2015cited by this paper
• Endogenous BDNF augments NMDA receptor phosphorylation in the spinal cord via PLCγ, PKC, and PI3K/Akt pathways during colitis

  2015cited by this paper
• Activation of mGluR5 Attenuates Microglial Activation and Neuronal Apoptosis in Early Brain Injury After Experimental Subarachnoid Hemorrhage in Rats

  2015cited by this paper
• Enhancement of endocannabinoid signalling protects against cocaine-induced neurotoxicity

  2015cited by this paper
• The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway

  2015cited by this paper
• Homer Protein–Metabotropic Glutamate Receptor Binding Regulates Endocannabinoid Signaling and Affects Hyperexcitability in a Mouse Model of Fragile X Syndrome

  2015cited by this paper
• The metabotropic glutamate receptor 5 role on motor behavior involves specific neural substrates

  2015cited by this paper
• The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease.

  2015cited by this paper
• Genetic rescue of CB1 receptors on medium spiny neurons prevents loss of excitatory striatal synapses but not motor impairment in HD mice.

  2014cited by this paper
• Novel mGluR5 Positive Allosteric Modulator Improves Functional Recovery, Attenuates Neurodegeneration, and Alters Microglial Polarization after Experimental Traumatic Brain Injury

  2014cited by this paper
• Metabotropic glutamate receptor 5 positive allosteric modulators are neuroprotective in a mouse model of Huntington's disease

  2013influential reference
• Disease-modifying drugs in Alzheimer’s disease

  2013cited by this paper
• Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition.

  2013cited by this paper
• Evidence for a role of GABAergic and glutamatergic signalling in the basolateral amygdala in endocannabinoid‐mediated fear‐conditioned analgesia in rats

  2013cited by this paper
• mGluR5 Ablation in Cortical Glutamatergic Neurons Increases Novelty-Induced Locomotion

  2013cited by this paper
• Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice

  2012cited by this paper
• Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome

  2012influential reference
• Interactions of CB1 and mGlu5 receptor antagonists in food intake, anxiety and memory models in rats.

  2012cited by this paper
• Protective Effects of mGluR5 Positive Modulators Against Traumatic Neuronal Injury Through PKC-Dependent Activation of MEK/ERK Pathway

  2012cited by this paper
• Zinc transporter ZnT-3 regulates presynaptic Erk1/2 signaling and hippocampus-dependent memory

  2011cited by this paper
• Phosphoinositide 3‐kinase γ plays a critical role in bleomycin‐induced pulmonary inflammation and fibrosis in mice

  2011cited by this paper
• Worsening of Huntington disease phenotype in CB1 receptor knockout mice.

  2011cited by this paper
• Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease

  2011cited by this paper
• Metabotropic Glutamate Receptor-Mediated Cell Signaling Pathways Are Altered in a Mouse Model of Huntington's Disease

  2010cited by this paper
• Pyk2 uncouples metabotropic glutamate receptor G protein signaling but facilitates ERK1/2 activation

  2010cited by this paper
• WIN55,212‐2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mouse model of Parkinson’s disease

  2009cited by this paper
• ERK activation in axonal varicosities modulates presynaptic plasticity in the CA3 region of the hippocampus through synapsin I

  2009cited by this paper
• Endocannabinoid-mediated control of synaptic transmission.

  2009cited by this paper
• Effects of Positive Allosteric Modulators on Single-Cell Oscillatory Ca2+ Signaling Initiated by the Type 5 Metabotropic Glutamate Receptor

  2009cited by this paper
• Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects

  2008cited by this paper
• Endocannabinoid signaling as a synaptic circuit breaker in neurological disease

  2008cited by this paper
• The p110β isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110γ

  2008cited by this paper
• Homer Interactions Are Necessary for Metabotropic Glutamate Receptor-Induced Long-Term Depression and Translational Activation

  2008cited by this paper
• Visual Stimulation Activates ERK in Synaptic and Somatic Compartments of Rat Cortical Neurons with Parallel Kinetics

  2007cited by this paper
• Neuronal subtype specification in the cerebral cortex

  2007cited by this paper
• A Key Role for Diacylglycerol Lipase-α in Metabotropic Glutamate Receptor-Dependent Endocannabinoid Mobilization

  2007cited by this paper
• Allosteric enhancement of metabotropic glutamate receptor 5 function promotes spatial memory.

  2006cited by this paper
• Synaptic scaffolding protein Homer1a protects against chronic inflammatory pain

  2006cited by this paper
• Allosteric Potentiators of Metabotropic Glutamate Receptor Subtype 5 Have Differential Effects on Different Signaling Pathways in Cortical Astrocytes

  2005cited by this paper
• Stimulation of Endocannabinoid Formation in Brain Slice Cultures through Activation of Group I Metabotropic Glutamate Receptors

  2005cited by this paper
• Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease.

  2005cited by this paper
• The Scaffold Protein Homer1b/c Links Metabotropic Glutamate Receptor 5 to Extracellular Signal-Regulated Protein Kinase Cascades in Neurons

  2005cited by this paper
• Synaptic Changes in Alzheimer ’ s Disease Increased Amyloid-and Gliosis in Surviving Terminals Is Accompanied by Decreased PSD-95 Fluorescence

  2004cited by this paper
• A Single In Vivo Exposure to Cocaine Abolishes Endocannabinoid-Mediated Long-Term Depression in the Nucleus Accumbens

  2004cited by this paper
• Activation of the Phosphoinositide 3-Kinase-Akt-Mammalian Target of Rapamycin Signaling Pathway Is Required for Metabotropic Glutamate Receptor-Dependent Long-Term Depression

  2004cited by this paper
• Regulation of Extracellular Signal-Regulated Kinase by Cannabinoids in Hippocampus

  2003cited by this paper
• PI3 kinase enhancer–Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis

  2003cited by this paper
• Modulation of anxiety through blockade of anandamide hydrolysis

  2003cited by this paper
• CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity

  2003influential reference
• Cooperative endocannabinoid production by neuronal depolarization and group I metabotropic glutamate receptor activation

  2002cited by this paper
• Brain monoglyceride lipase participating in endocannabinoid inactivation

  2002cited by this paper
• Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses

  2001cited by this paper
• Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals.

  2001cited by this paper
• The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt.

  2000cited by this paper
• Presynaptically Located CB1 Cannabinoid Receptors Regulate GABA Release from Axon Terminals of Specific Hippocampal Interneurons

  1999cited by this paper
• Mice Lacking Metabotropic Glutamate Receptor 5 Show Impaired Learning and Reduced CA1 Long-Term Potentiation (LTP) But Normal CA3 LTP

  1997cited by this paper
• Biosynthesis of an Endogenous Cannabinoid Precursor in Neurons and its Control by Calcium and cAMP

  1996cited by this paper
• Comparison of nociceptive effects produced by intrathecal administration of mGluR agonists.

  1996cited by this paper
• Cannabinoid Receptor Agonists Inhibit Glutamatergic Synaptic Transmission in Rat Hippocampal Cultures

  1996cited by this paper
• The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide

  1995cited by this paper
• Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain.

  1995cited by this paper
• Partial Purification and Characterization of the Porcine Brain Enzyme Hydrolyzing and Synthesizing Anandamide (*)

  1995cited by this paper
• Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1.

  1995cited by this paper
• A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002).

  1994cited by this paper
• Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain.

  1993cited by this paper
• Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

  1991cited by this paper
• Calcium‐Dependent and‐Independent Release of Glutamate from Synaptosomes Monitored by Continuous Fluorometry

  1987influential reference
• A new generation of Ca2+ indicators with greatly improved fluorescence properties.

  1985cited by this paper

• Learning a Foreign Language in Older Adults Shapes the Functional Connectivity of Distinct Cerebellar Sub‐Regions With Cortical Areas Rich in CB1 Receptor Expression

  2025cites this paper
• Effects of Progressive Aerobic Training on Executive-Reward Network Connectivity and Symptoms of Internet Gaming Disorder: Randomized Controlled Trial

  2025cites this paper
• Unlocking the therapeutic capabilities of GPCR in the treatment of ischemic stroke: A translational literature

  2024cites this paper
• CB1 Receptor Activation Provides Neuroprotection in an Animal Model of Glutamate‐Induced Excitotoxicity Through a Reduction of NOX‐2 Activity and Oxidative Stress

  2024cites this paper
• Evidence for functional interaction between the CB1 and the mGlu7 mediated signaling in modulation of anxiety behavior and cognition.

  2024cites this paper
• Interactions between metabotropic glutamate and CB1 receptors: implications for mood, cognition, and synaptic signaling based on data from mGluR and CB1R-targeting drugs

  2024cites this paper
• Repeated cannabidiol treatment affects neuroplasticity and endocannabinoid signaling in the prefrontal cortex of the Flinders Sensitive Line (FSL) rat model of depression.

  2024cites this paper
• CBD enhances the cognitive score of adolescent rats prenatally exposed to THC and fine-tunes relevant effectors of hippocampal plasticity

  2023cites this paper
• Prenatal Exposure to Δ9-Tetrahydrocannabinol Affects Hippocampus-Related Cognitive Functions in the Adolescent Rat Offspring: Focus on Specific Markers of Neuroplasticity

  2023cites this paper
• Neuroprotection and Beyond: The Central Role of CB1 and CB2 Receptors in Stroke Recovery

  2023cites this paper
• Reward enhances resilience to chronic social defeat stress in mice: Neural ECs and mGluR5 mechanism via neuroprotection in VTA and DRN

  2023cites this paper
• Metabotropic glutamate receptor 5 upregulation of γ-aminobutyric acid transporter 3 expression ameliorates cognitive impairment after traumatic brain injury in mice.

  2022cites this paper
• Anandamide Hydrolysis Inhibition Reverses the Long-Term Behavioral and Gene Expression Alterations Induced by MK-801 in Male Rats: Differential CB1 and CB2 Receptor-Mediated Effects.

  2022cites this paper
• Metabotropic glutamate receptor 5 blockade attenuates pathological cardiac remodelling in pulmonary arterial hypertension

  2022cites this paper
• scDVF: Single-cell Transcriptomic Deep Velocity Field Learning with Neural Ordinary Differential Equations

  2022cites this paper
• DeepVelo: Single-cell transcriptomic deep velocity field learning with neural ordinary differential equations

  2022cites this paper
• Modulation of mGlu5 improves sensorimotor gating deficits in rats neonatally treated with quinpirole through changes in dopamine D2 signaling.

  2021cites this paper
• Targeting the inhibition of fatty acid amide hydrolase ameliorate the endocannabinoid-mediated synaptic dysfunction in a valproic acid-induced rat model of Autism.

  2020cites this paper
• NEUROPROTECTIVE EFFECT OF ORGANIC ACIDS DIAMIDES. FOCUS ON CHANGING MITOCHONDRIAL FUNCTION

  2020cites this paper
• Differential mechanisms of tolerance induced by NMDA and 3,5‐dihydroxyphenylglycine (DHPG) preconditioning

  2020cites this paper
• Enhanced Akt/GSK‐3β/CREB signaling mediates the anti‐inflammatory actions of mGluR5 positive allosteric modulators in microglia and following traumatic brain injury in male mice

  2020influential citation
• A positive allosteric modulator of mGluR5 promotes neuroprotective effects in mice models of Alzheimer's disease.

  2019cites this paper
• The mGluR5 positive allosteric modulator VU0409551 improves synaptic plasticity and memory of a mouse model of Huntington's disease

  2018cites this paper
• Identification phénoménologique des substrats neurobiologiques de la relation impulsivité / compulsivité : approche transnosographique

  2017cites this paper
• mGluR5, CB1 and neuroprotection

  2016cites this paper